Bilcare P/E Ratio
Bilcare (BI) P/E ratio is not applicable — EPS (TTM) ₹-12.23, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹-12.23
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -5.25 | -23 | Loss |
| Mar 2025 | 4.48 | 5 | Profit |
| Jun 2025 | -1.61 | -10 | Loss |
| Dec 2025 | -2.53 | -13 | Loss |
| Sept 2024 | -6.81 | -30 | Loss |
| Mar 2024 | -4.63 | -20 | Loss |
| Jun 2024 | -2.71 | -15 | Loss |
| Jun 2024 | -2.71 | -15 | Loss |
Healthcare Peers with Valid P/E Ratios — BI Comparison
Healthcare sector average P/E 49.05, median 29.34 — BI excluded (negative EPS).
Sector Average PE
49.05
Sector Median PE
29.34
Lowest PE
0.97
Profitable Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Bilcare screener.
- Browse BI cash flow statement for revenue, profit, balance sheet and cash flow data.
- Analyse Bilcare ownership structure to track promoter, FII and institutional holdings.